KR

Kamapalan Rajendra Prasad

Active Director Director DIN 10552734
DIN 10552734 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamapalan Rajendra Prasad

Data last updated:

Kamapalan Rajendra Prasad is a Director at Devaprasad Eye Hospitals Private Limited (since 2024). The company operates in Healthcare.

DIN 10552734
Primary Designation Director
Industry Healthcare
First Appointment 16 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Mar 20242024Active

Board colleagues of Kamapalan Rajendra Prasad

NameDINCompanyDesignation
Suseela Kochadichan Karimundackal02785658Devaprasad Eye Hospitals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Devaprasad Eye Hospitals Private Limited
Premium access

Shareholding and investment profile for Kamapalan Rajendra Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamapalan Rajendra Prasad

Kamapalan Rajendra Prasad currently holds 1 directorship: Devaprasad Eye Hospitals Private Limited (Director, since 16 Mar 2024).

Kamapalan Rajendra Prasad was first appointed on 16 Mar 2024 as Director at Devaprasad Eye Hospitals Private Limited.

The current boards of Kamapalan Rajendra Prasad's companies include Suseela Kochadichan Karimundackal (Devaprasad Eye Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available